New Hope for Migraine Sufferers: CGRP Inhibitors Offer Breakthrough Relief
June 11, 2025 — Health Desk
In a major breakthrough for migraine sufferers, a new class of medications known as CGRP inhibitors is showing promising results in both reducing the frequency and intensity of debilitating migraine attacks.
CGRP (Calcitonin Gene-Related Peptide) is a protein known to play a key role in migraine pathophysiology. During an attack, levels of CGRP rise, leading to inflammation and dilation of blood vessels in the brain. CGRP inhibitors work by either blocking the CGRP molecule or its receptor, thereby preventing this cascade.
Over the past few years, several CGRP-targeting drugs—like erenumab, fremanezumab, and galcanezumab—have been approved for clinical use, offering new hope for individuals who have failed to find relief with traditional migraine therapies.
“For patients who have tried everything from triptans to lifestyle changes, CGRP inhibitors can be life-changing,” says Dr. Nina Sharma, a neurologist at Mumbai General Hospital. “They’re not only effective but also well-tolerated, with minimal side effects.”
Unlike acute treatments taken during an attack, many CGRP inhibitors are used preventatively, reducing monthly migraine days by 50% or more in some cases. Patients report improvements in quality of life, productivity, and mental health.
Despite the excitement, cost remains a hurdle. “Access to these drugs is limited in many countries due to their high price point,” says Dr. Sharma. “Advocacy for insurance coverage and government support is crucial to make this therapy widely available.”
With more research underway, experts believe CGRP inhibitors may eventually be useful for other pain-related conditions, including cluster headaches and fibromyalgia.
As awareness grows and costs begin to come down, CGRP inhibitors may become a standard tool in the fight against one of the most disabling neurological disorders worldwide.
📰 Occupational Health Takes Center Stage Amid Shifting Workplace Norms
June 11, 2025 — Business & Health News
As businesses adapt to a post-pandemic world and a growing remote workforce, occupational health is emerging as a key focus area for employers across the globe.
Once a niche field concerned largely with physical safety and compliance, occupational health has evolved to encompass mental well-being, ergonomic support, chronic disease management, and workplace inclusivity.
“The modern workplace looks nothing like it did a decade ago,” says Arjun Mehta, Director of Workplace Health at a leading multinational. “Today, occupational health is not just about preventing injuries—it's about promoting holistic well-being.”
Companies are increasingly investing in occupational health services, including telehealth consultations, employee assistance programs (EAPs), fitness subsidies, and mental health days. In India, recent surveys indicate that nearly 68% of HR managers now view employee well-being as a strategic priority, compared to just 42% in 2018.
The rise of remote and hybrid work models has also shifted the focus to ergonomics and digital fatigue. “People are now working from couches and kitchen tables,” says physiotherapist Dr. Rhea D'Souza. “We're seeing a rise in repetitive strain injuries and posture-related issues that weren’t common before.”
Governments are stepping in as well. In 2024, India’s Ministry of Labour introduced new workplace wellness guidelines, urging companies to create safer, more inclusive, and health-conscious environments.
Yet challenges persist. Many small and medium-sized enterprises (SMEs) still lack the resources to implement comprehensive occupational health programs. Experts argue for public-private partnerships to bridge this gap.
“Healthy employees are productive employees,” says Mehta. “In the long run, investing in occupational health isn’t just the right thing to do—it’s good business.”
As workplace expectations continue to evolve, one thing is clear: occupational health is no longer optional—it’s essential.